A randomised double blinded placebo controlled trial of adrenaline in cardiac arrest

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN22893536

Enrollment

2250

Registered

2003-03-27

Start date

2005-01-01

Completion date

Unknown

Last updated

2021-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest Circulatory System Cardiac arrest

Interventions

Patients meeting the above criteria were randomised to receive either placebo administered intravenously (Control arm) or intravenous adrenaline according to standard resuscitation treatment guideline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients in cardiac arrest upon arrival of Ambulance Paramedics in whom resuscitation is initiated

Exclusion criteria

Exclusion criteria: 1. Patients under the age of 18 years 2. Patients in which advanced life support was not commenced (i.e. deceased before ambulance arrival)

Design outcomes

Primary

Measure	Time frame
Survival to hospital discharge	—

Secondary

Measure	Time frame
1. Return of spontaneous circulation 2. Survival at one year	—

Countries

Australia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026